CAC Software vs DeepTek CXR Analyzer

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by 4DMedical (Imbio CAC Software)
VS
by DeepTek

AI Verdict

Tool A is specifically designed for quantitative analysis of coronary artery calcification from non-contrast chest CT scans, providing detailed metrics for cardiovascular risk assessment. Tool B, conversely, is a broader AI-powered CADe solution for chest X-rays, assisting radiologists by detecting and highlighting a wide range of lung, pleural, and cardiac pathologies. While both operate in medical imaging AI, their distinct imaging modalities and specific analytical focus make them suitable for different diagnostic needs.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary need is automated, quantitative analysis of coronary artery calcification from non-contrast chest CT scans. This tool is ideal for precisely determining Agatston scores, arterial age, and calcified lesion volume to support cardiovascular risk assessment and patient management.

View CAC Software →

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if you require an AI-powered solution to enhance the efficiency and accuracy of chest X-ray interpretation across a wide range of pathologies. This tool is best suited for automatically detecting and highlighting suspicious regions in lung, pleural, and cardiac areas, thereby reducing radiologist workload and accelerating diagnostic workflows.

View DeepTek CXR Analyzer →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software DeepTek CXR Analyzer
Pricing Unknown Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.
Deployment Cloud-based (SaaS), integrates with PACS On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepTek CXR Analyzer

DeepTek CXR Analyzer explicitly highlights features like intelligent scan segregation and claims of significantly reducing radiologist workload by 30-50% and boosting productivity by 2x-3%, which directly translate to superior workflow efficiency and ease of use. While Tool A offers automated analysis and 3D visualizations, Tool B's focus on streamlining the interpretation process for a high-volume modality like CXR gives it an edge in practical usability.

Clinical Value

DeepTek CXR Analyzer

DeepTek CXR Analyzer offers broader clinical utility by detecting 28 pathologies on chest X-rays, a high-volume screening modality, and has demonstrated improved diagnostic accuracy and sensitivity for radiologists. Its WHO recommendation for TB screening and ability to interpret pediatric X-rays further highlight its significant public health impact and versatility across patient demographics. While Tool A provides valuable quantitative risk assessment for CAD, Tool B's wider scope and proven impact on diagnostic performance for a common imaging type give it an edge.

Pricing & Value

DeepTek CXR Analyzer

DeepTek CXR Analyzer offers greater transparency and flexibility with its 'Pay-per-use' model and options for technology offering or AI-assisted reporting service. This allows customers to better align costs with usage and choose a service model that best fits their needs. Tool A's generic 'contact for pricing' offers no such immediate clarity or flexibility.

Enterprise Readiness

DeepTek CXR Analyzer

While both tools are FDA cleared, HIPAA compliant, and offer flexible deployment, DeepTek CXR Analyzer provides a more comprehensive list of additional certifications including GDPR, SOC 2, ISO 27001, and various medical device standards. This extensive compliance portfolio, coupled with its deployment as a national radiology AI platform, indicates a higher level of enterprise readiness and commitment to robust security and quality management.

Innovation

DeepTek CXR Analyzer

DeepTek CXR Analyzer demonstrates broader innovation through its ability to detect 28 pathologies on chest X-rays, intelligent scan segregation, and significant workflow efficiency improvements for radiologists. Furthermore, its features like domain shift and foreign object detectors, alongside its capability for rapid, offline analysis in remote settings for public health screening, showcase a wider and more impactful range of innovative applications.

Support & Docs

Tie

Both Imbio and DeepTek provide standard support channels including email and phone, along with accessible documentation such as user manuals and installation guides. The available information does not provide sufficient detail to definitively distinguish the quality or comprehensiveness of their support and documentation offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software DeepTek CXR Analyzer
Name CAC Software DeepTek CXR Analyzer
Company Imbio DeepTek Medical Imaging Pvt
Description Automated image post-processing algorithms to determine location and calculate calcification in coronary arteries from non-contrast chest CT. AI-powered CADe solution for chest X-ray analysis, assisting radiologists by detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies.
Primary Imaging Modality Non-contrast Chest CT Chest X-ray
Key Output/Function Quantification of coronary artery calcification, Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations. Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware; automatic identification and highlighting of suspicious regions.
Specialties Cardiology, Radiology Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring CAC Software and DeepTek CXR Analyzer.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's Coronary Artery Calcification (CAC) software is designed to analyze non-contrast chest CT scans to determine the location and amount of calcification within the coronary arteries. DeepTek CXR Analyzer, on the other hand, is an AI-powered computer-assisted detection (CADe) solution specifically for chest X-ray analysis, compatible with various X-ray modalities.
Imbio's CAC Software quantifies calcified plaques in the coronary arteries, providing an Agatston score, arterial age, calcified lesion mass, and volume metrics to aid in risk assessment for coronary artery disease. DeepTek CXR Analyzer automatically detects and highlights suspicious regions across 28 findings covering lung, pleural, and cardiac pathologies, as well as hardware, to assist radiologists in their interpretations.
Imbio's CAC Software is designed to integrate into existing DICOM viewing workflows, providing 3D visualizations and annotated images as part of the standard workflow. DeepTek CXR Analyzer offers seamless DICOM-based PACS integration, working in the backend (on-premise or cloud) without altering current workflows and sending secondary capture DICOM with AI output back to PACS.
Imbio's CAC Software provides automated image post-processing and quantification of coronary artery calcification, supporting risk assessment for coronary artery disease. DeepTek CXR Analyzer aims to reduce radiologist workload by 30-50% and boost productivity by 2x-3x by intelligently segregating scans into 'AI Finding-Negative' and 'AI Finding-Positive' and highlighting suspicious regions.
Imbio's CAC Software outputs a summary report containing the Agatston score, arterial age, calcified lesion mass, and volume metrics, along with annotated images previewing the segmentation of calcifications. DeepTek CXR Analyzer provides automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs) with bounding boxes, and generates secondary capture DICOM with AI output for easy interpretation.
AI Tool Finder
AI-powered search. Results may not be comprehensive.